AstraZeneca shares seen slipping 3% after reported Bristol Myers talks
AstraZeneca shares are expected to drop up to 3% on Monday following reports of preliminary talks with Bristol Myers Squibb about a possible combination.
- Country:
- United States
AstraZeneca shares are expected to drop up to 3% on Monday, according to traders, after reports that the European pharmaceutical giant held preliminary talks about a possible combination with U.S.-based Bristol Myers Squibb.
Google News